N
Engl J Med 1993 Jul 29;329(5):326-31
Comment in:
N Engl J Med. 1993 Dec 30;329(27):2039-40.
The relation between health insurance coverage and clinical outcomes
among women with breast cancer.
Ayanian JZ, Kohler BA, Abe T, Epstein AM.
Department of Medicine, Brigham and Women's Hospital, Boston, MA.
BACKGROUND. Women without private health insurance are
less likely than privately insured women to be screened for breast cancer,
and their treatment may differ after cancer is diagnosed. In this study
we addressed two related questions: Do uninsured patients and those covered
by Medicaid have more advanced breast cancer than privately insured patients
when the disease is initially diagnosed? And, for each stage of disease,
do uninsured patients and patients covered by Medicaid die sooner after
breast cancer is diagnosed than privately insured patients?
METHODS. We studied 4675 women, 35 to 64 years of age,
in whom invasive breast
cancer was diagnosed from 1985 through 1987, by linking New Jersey State
Cancer Registry records to hospital-discharge data. We compared the stage
of disease and stage-specific survival among women with private insurance,
no insurance, and Medicaid coverage through June 1992. We also estimated
the adjusted risk of death for these groups, using proportional-hazards
regression analysis to control for age, race, marital status, household
income, coexisting diagnoses, and disease stage.
RESULTS. Uninsured patients and those covered by Medicaid
presented with more advanced disease than did privately insured patients
(P < 0.001 and P = 0.01, respectively). Survival was worse for uninsured
patients and those with Medicaid coverage than for privately insured patients
with local disease (P < 0.001 for both comparisons) and regional disease
(P < 0.001 for both comparisons), but not distant metastases. The adjusted
risk of death was 49 percent higher (95 percent confidence interval, 20
to 84 percent) for uninsured patients and 40 percent higher (95 percent
confidence interval, 4 to 89 percent) for Medicaid patients than for privately
insured patients during the 54 to 89 months after diagnosis.
CONCLUSIONS. The more frequent adverse outcomes of breast
cancer among women without private health insurance suggest that such
women would benefit from improved access to screening and optimal therapy.
PMID: 8321261 [PubMed - indexed for MEDLINE]
N Engl J Med 1993 Dec 30;329(27):2039-40
Comment on:
N Engl J Med. 1993 Jul 29;329(5):326-31.
Health insurance coverage and clinical outcomes in women with breast cancer.
Hamilton V, Benk V, Fortin P.
Publication Types: Comment; Letter
PMID: 8247090 [PubMed - indexed for MEDLINE]